Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 124.66 Thousand USD | -22.65% |
| 2023 | 161.16 Thousand USD | 28.88% |
| 2022 | 125.04 Thousand USD | 35.95% |
| 2021 | 91.98 Thousand USD | -36.96% |
| 2020 | 145.89 Thousand AUD | 29.69% |
| 2019 | 112.49 Thousand AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 14.35 Thousand AUD | -24.98% |
| 2007 | 19.12 Thousand AUD | 0.0% |
| 2006 | - AUD | -100.0% |
| 2005 | 13.34 Thousand AUD | 9.06% |
| 2004 | 12.23 Thousand AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 9570.99 AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | -100.0% |
| 1999 | 2.93 Billion AUD | 1524699.67% |
| 1998 | 192.73 Thousand AUD | -19.86% |
| 1997 | 240.51 Thousand AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| 1992 | - AUD | 0.0% |
| 1991 | - AUD | 0.0% |
| 1990 | - AUD | 0.0% |
| 1989 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 93.18 Thousand USD | 0.0% |
| 2024 FY | 124.66 Thousand USD | -22.65% |
| 2023 FY | 161.16 Thousand USD | 28.88% |
| 2023 Q2 | 77.79 Thousand USD | 0.0% |
| 2023 Q4 | 83.33 Thousand USD | 0.0% |
| 2022 Q2 | 124.69 Thousand USD | 0.0% |
| 2022 Q4 | 66.09 Thousand USD | 0.0% |
| 2022 FY | 125.04 Thousand USD | 35.95% |
| 2021 FY | 91.98 Thousand USD | -36.96% |
| 2021 Q2 | 41.46 Thousand USD | 0.0% |
| 2020 Q4 | -127.32 Thousand AUD | 0.0% |
| 2020 FY | 145.89 Thousand AUD | 29.69% |
| 2020 Q2 | 273.11 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | 112.49 Thousand AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q2 | - AUD | -100.0% |
| 2009 Q1 | 3750.00 AUD | 0.0% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q3 | 3750.00 AUD | 0.0% |
| 2008 Q2 | 3750.00 AUD | -33.49% |
| 2008 Q1 | 5638.50 AUD | 0.0% |
| 2008 FY | 14.35 Thousand AUD | -24.98% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 19.12 Thousand AUD | 0.0% |
| 2007 Q1 | - AUD | 0.0% |
| 2007 Q2 | 5638.50 AUD | 0.0% |
| 2007 Q3 | 5638.50 AUD | 0.0% |
| 2006 Q3 | - AUD | 0.0% |
| 2006 FY | - AUD | -100.0% |
| 2006 Q1 | 4375.00 AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 Q2 | - AUD | -100.0% |
| 2005 FY | 13.34 Thousand AUD | 9.06% |
| 2005 Q1 | 4375.00 AUD | 0.0% |
| 2005 Q2 | 4375.00 AUD | 0.0% |
| 2005 Q3 | 4375.00 AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2004 Q3 | 4375.00 AUD | 0.0% |
| 2004 FY | 12.23 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2004 Q2 | 4375.00 AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q2 | - AUD | -100.0% |
| 2003 Q3 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2003 Q1 | 4250.00 AUD | 0.0% |
| 2002 Q2 | 4250.00 AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 Q3 | 4250.00 AUD | 0.0% |
| 2002 FY | 9570.99 AUD | 0.0% |
| 2002 Q1 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 FY | - AUD | -100.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | 2.93 Billion AUD | 1524699.67% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1998 Q1 | 79.78 Thousand AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 FY | 192.73 Thousand AUD | -19.86% |
| 1997 FY | 240.51 Thousand AUD | 0.0% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 Q2 | 79.78 Thousand AUD | 0.0% |
| 1997 Q3 | 79.78 Thousand AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1992 Q2 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| 1992 FY | - AUD | 0.0% |
| 1992 Q1 | - AUD | 0.0% |
| 1992 Q3 | - AUD | 0.0% |
| 1991 Q3 | - AUD | 0.0% |
| 1991 FY | - AUD | 0.0% |
| 1991 Q1 | - AUD | 0.0% |
| 1991 Q2 | - AUD | 0.0% |
| 1991 Q4 | - AUD | 0.0% |
| 1990 FY | - AUD | 0.0% |
| 1990 Q1 | - AUD | 0.0% |
| 1990 Q3 | - AUD | 0.0% |
| 1990 Q2 | - AUD | 0.0% |
| 1990 Q4 | - AUD | 0.0% |
| 1989 Q4 | - AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q2 | - AUD | 0.0% |
| 1989 Q3 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.812% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -31.294% |
| Biome Australia Limited | 13 Million AUD | 99.042% |
| Patrys Limited | 1.39 Million AUD | 91.058% |
| Orthocell Limited | 5.31 Million AUD | 97.655% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | 2.4 Million AUD | 94.806% |
| PYC Therapeutics Limited | 22.05 Million AUD | 99.435% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 98.328% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 96.642% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 86.026% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 94.616% |
| CSL Limited | 22.41 Billion AUD | 99.999% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -633.329% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -580.491% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.859% |
| Starpharma Holdings Limited | 8.28 Million AUD | 98.496% |
| Nanollose Limited | 12.5 Thousand AUD | -897.248% |
| Memphasys Limited | 60 Thousand AUD | -107.777% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 89.716% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 97.2% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 79.285% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 90.039% |
| Race Oncology Limited | 4 Million AUD | 96.886% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.975% |
| Dimerix Limited | 583.47 Thousand AUD | 78.634% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 96.444% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 98.917% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 96.898% |
| BTC Health Limited | 16.36 Thousand AUD | -662.017% |
| Acrux Limited | 5.09 Million AUD | 97.551% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.946% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | 152.24 Thousand AUD | 18.112% |
| AdAlta Limited | 1.73 Million AUD | 92.826% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | 58.337% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 72.922% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -89.462% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | 73.674% |
| Actinogen Medical Limited | 9.93 Million AUD | 98.745% |
| Immuron Limited | 4.9 Million AUD | 97.457% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 95.201% |